Debate: Prasugrel rather than ticagrelor is the preferred treatment for NSTE-ACS patients who proceed to PCI and pretreatment should not be performed in patients planned for an early invasive strategy

Risultato della ricerca: Contributo in rivistaArticolo in rivista

Abstract

N/A
Lingua originaleEnglish
pagine (da-a)2973-2985
Numero di pagine13
RivistaEuropean Heart Journal
Volume42
DOI
Stato di pubblicazionePubblicato - 2021

Keywords

  • Clopidogrel
  • Humans
  • Percutaneous Coronary Intervention
  • Purinergic P2Y Receptor Antagonists
  • Ticagrelor
  • Prasugrel Hydrochloride

Fingerprint

Entra nei temi di ricerca di 'Debate: Prasugrel rather than ticagrelor is the preferred treatment for NSTE-ACS patients who proceed to PCI and pretreatment should not be performed in patients planned for an early invasive strategy'. Insieme formano una fingerprint unica.

Cita questo